LIPO
Lipella Pharmaceuticals Inc

1,902
Mkt Cap
$138,625.00
Volume
122,635.00
52W High
$3.17
52W Low
$0.0197
PE Ratio
-0.02
LIPO Fundamentals
Price
$0.0371
Prev Close
$0.03
Open
$0.0251
50D MA
$0.1328
Beta
0.69
Avg. Volume
17,685.05
P/B
0.12
Loading...
Loading...

About

Lipella Pharmaceuticals, Inc. develops and commercializes lipid-based therapies for common bladder syndromes. It offers LP-08 which consists of Sphingomyelin Phospholipid bilayers separated by aqueous compartments, LP-09, a liposomal formulation of Botulinum toxin, and LP-10, a proprietary liposomal formulation of Tacrolimus, a potent immunosuppressant and anti-inflammatory agent. The company was founded by Jonathan Kaufman and Michael Chancellor on February 15, 2005 and is headquartered in Pittsburgh, PA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Lipella Pharmaceuticals Inc?
What is the 52-week high for Lipella Pharmaceuticals Inc?
What is the 52-week low for Lipella Pharmaceuticals Inc?
What is Lipella Pharmaceuticals Inc stock price today?
What was Lipella Pharmaceuticals Inc stock price yesterday?
What is the PE ratio of Lipella Pharmaceuticals Inc?
What is the Price-to-Book ratio of Lipella Pharmaceuticals Inc?
What is the 50-day moving average of Lipella Pharmaceuticals Inc?

Latest LIPO News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.